Terms ending in 2026
Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2026, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,816,380 | 1-Hydroxycycloalkanecarboxamide Derivatives In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,569,592 | Heteroaryl Substituted Pyrazole Modulators of Metabotropic Glutamate RECEPTOR-5 In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,625,938 | Substituted Pyrazoles, Compositions Containing Such Compounds and Methods of Use In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,618,985 | Isoquinoline Derivatives In force · High confidence | Merck Sharp & Dohme B.V. | In force | High confidence | |
| US 8,486,983 | Self-Emulsifying Formulations of Cetp Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,528,132 | Kinase Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,298,543 | Identification and Application of Antibiotic Synergy In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,888,369 | Oxazoloisoquinoline Derivatives as Thrombin Receptor Antagonists In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,547,720 | Ophthalmic Compositions for Treating Ocular Hypertension In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,709,658 | Process for Synthesizing a Substituted Pyrazole In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| 3 more term ends in 2026 · Pro | |||||
10 of 13 patents shown. Soonest term end first, then patent number.
Pro members see all 13, all of them expiring within the 18 months from Nov 17, 2026.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.